FDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review

Published date28 July 2020
AuthorDelia A. Deschaine, James Boiani and Megan Robertson
Subject MatterHealth Care
Law FirmEpstein Becker & Green, P.C.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT